Miller DD - Search Results

1

Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.

He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, Miller DD. He Y, et al. Among authors: miller dd. Bioorg Med Chem. 2022 Jan 1;53:116533. doi: 10.1016/j.bmc.2021.116533. Epub 2021 Nov 27. Bioorg Med Chem. 2022. PMID: 34863065

2

Synthesis of chiral 1-(2'-amino-2'-carboxyethyl)-1,4-dihydro-6,7-quinoxaline-2,3-diones: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor agonists and antagonists.

Sun G, Uretsky NJ, Wallace LJ, Shams G, Weinstein DM, Miller DD. Sun G, et al. Among authors: miller dd. J Med Chem. 1996 Oct 25;39(22):4430-8. doi: 10.1021/jm950632+. J Med Chem. 1996. PMID: 8893837

3

Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket".

Zhang X, De Los Angeles JE, He MY, Dalton JT, Shams G, Lei L, Patil PN, Feller DR, Miller DD, Hsu FL. Zhang X, et al. Among authors: miller dd. J Med Chem. 1997 Sep 12;40(19):3014-24. doi: 10.1021/jm960642q. J Med Chem. 1997. PMID: 9301663

4

Design and synthesis of enantiomers of 3,5-dinitro-o-tyrosine: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonists.

Sun G, Slavica M, Uretsky NJ, Wallace LJ, Shams G, Weinstein DM, Miller JC, Miller DD. Sun G, et al. Among authors: miller dd, miller jc. J Med Chem. 1998 Mar 26;41(7):1034-41. doi: 10.1021/jm970276q. J Med Chem. 1998. PMID: 9544203

5

2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.

Zheng W, Nikulin VI, Konkar AA, Vansal SS, Shams G, Feller DR, Miller DD. Zheng W, et al. Among authors: miller dd. J Med Chem. 1999 Jun 17;42(12):2287-94. doi: 10.1021/jm990012z. J Med Chem. 1999. PMID: 10377236

6

Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro.

He Y, Nikulin VI, Vansal SS, Feller DR, Miller DD. He Y, et al. Among authors: miller dd. J Med Chem. 2000 Feb 24;43(4):591-8. doi: 10.1021/jm990463j. J Med Chem. 2000. PMID: 10691685

7

Yohimbine dimers exhibiting binding selectivities for human alpha2a- versus alpha2b-adrenergic receptors.

Zheng W, Lei L, Lalchandani S, Sun G, Feller DR, Miller DD. Zheng W, et al. Among authors: miller dd. Bioorg Med Chem Lett. 2000 Apr 3;10(7):627-30. doi: 10.1016/s0960-894x(00)00068-8. Bioorg Med Chem Lett. 2000. PMID: 10762040

8

Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.

He Y, Yin D, Perera M, Kirkovsky L, Stourman N, Li W, Dalton JT, Miller DD. He Y, et al. Among authors: miller dd. Eur J Med Chem. 2002 Aug;37(8):619-34. doi: 10.1016/s0223-5234(02)01335-1. Eur J Med Chem. 2002. PMID: 12161060

9

Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, Kirkovsky L, Miller DD, Dalton JT. Yin D, et al. Among authors: miller dd. Mol Pharmacol. 2003 Jan;63(1):211-23. doi: 10.1124/mol.63.1.211. Mol Pharmacol. 2003. PMID: 12488554

10

Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor.

Yin D, Xu H, He Y, Kirkovsky LI, Miller DD, Dalton JT. Yin D, et al. Among authors: miller dd. J Pharmacol Exp Ther. 2003 Mar;304(3):1323-33. doi: 10.1124/jpet.102.040832. J Pharmacol Exp Ther. 2003. PMID: 12604713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters